Hiroyuki Endo

Contrast-free closure of patent ductus arteriosus guided by real-time intracardiac echocardiography.

Journal: Cardiovascular intervention and therapeutics

Published: May 11, 2026

Pulmonary Venous Vasculopathy in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension With Reduced Diffusion Capacity for Carbon Monoxide.

Journal: Pulmonary circulation

Published: October 31, 2025

Long-term outcome of patients with Eisenmenger syndrome receiving pulmonary arterial hypertension-targeted therapy.

Journal: Open heart

Published: September 09, 2025

Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.

Journal: Open heart

Published: June 30, 2025

Kawasaki Disease Survivor With Progressive Coronary Vascular Remodeling and Ischemic Cardiomyopathy: A Case of a Heart Transplantation Recipient.

Journal: Pathology international

Published: April 29, 2025

Balloon Pulmonary Angioplasty in Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension.

Journal: Journal of the American Heart Association

Published: April 16, 2025

Long-term outcome of manual aspiration thrombectomy for acute proximal deep vein thrombosis.

Journal: Cardiovascular intervention and therapeutics

Published: December 29, 2024

Survival trends in patients with chronic thromboembolic pulmonary hypertension: an observational study.

Journal: The European respiratory journal

Published: November 14, 2024

Phase 2 Study to Evaluate the Efficacy and Safety of Inhaled Nitric Oxide Therapy in Patients With Severe Right Heart Failure Associated With Pulmonary Hypertension　- Protocol for the PHiNO Study.

Journal: Circulation reports

Published: October 15, 2024

The clinical impact of acute vasoreactivity testing in patients with severe pulmonary hypertension associated with lung disease: A retrospective exploratory analysis.

Journal: Respiratory investigation

Published: September 10, 2024

Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension.

Journal: Journal of the American Heart Association

Published: July 26, 2024

Clinical outcomes of upfront combination therapy for portopulmonary hypertension.

Journal: International journal of cardiology. Cardiovascular risk and prevention

Published: April 18, 2024

Contrast-free closure of patent ductus arteriosus guided by real-time intracardiac echocardiography.

Contrast-free closure of patent ductus arteriosus guided by real-time intracardiac echocardiography.

Pulmonary Venous Vasculopathy in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension With Reduced Diffusion Capacity for Carbon Monoxide.

Pulmonary Venous Vasculopathy in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension With Reduced Diffusion Capacity for Carbon Monoxide.

Long-term outcome of patients with Eisenmenger syndrome receiving pulmonary arterial hypertension-targeted therapy.

Long-term outcome of patients with Eisenmenger syndrome receiving pulmonary arterial hypertension-targeted therapy.

Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.

Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.

Kawasaki Disease Survivor With Progressive Coronary Vascular Remodeling and Ischemic Cardiomyopathy: A Case of a Heart Transplantation Recipient.

Kawasaki Disease Survivor With Progressive Coronary Vascular Remodeling and Ischemic Cardiomyopathy: A Case of a Heart Transplantation Recipient.

Balloon Pulmonary Angioplasty in Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension.

Balloon Pulmonary Angioplasty in Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension.

Long-term outcome of manual aspiration thrombectomy for acute proximal deep vein thrombosis.

Long-term outcome of manual aspiration thrombectomy for acute proximal deep vein thrombosis.

Survival trends in patients with chronic thromboembolic pulmonary hypertension: an observational study.

Survival trends in patients with chronic thromboembolic pulmonary hypertension: an observational study.

Phase 2 Study to Evaluate the Efficacy and Safety of Inhaled Nitric Oxide Therapy in Patients With Severe Right Heart Failure Associated With Pulmonary Hypertension - Protocol for the PHiNO Study.

Phase 2 Study to Evaluate the Efficacy and Safety of Inhaled Nitric Oxide Therapy in Patients With Severe Right Heart Failure Associated With Pulmonary Hypertension - Protocol for the PHiNO Study.

The clinical impact of acute vasoreactivity testing in patients with severe pulmonary hypertension associated with lung disease: A retrospective exploratory analysis.

The clinical impact of acute vasoreactivity testing in patients with severe pulmonary hypertension associated with lung disease: A retrospective exploratory analysis.

Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension.

Prevalence and Clinical Characteristics of Heterozygous RNF213 p.Arg4810Lys Variant Carriers Diagnosed With Chronic Thromboembolic Pulmonary Hypertension.

Clinical outcomes of upfront combination therapy for portopulmonary hypertension.

Clinical outcomes of upfront combination therapy for portopulmonary hypertension.

Phase 2 Study to Evaluate the Efficacy and Safety of Inhaled Nitric Oxide Therapy in Patients With Severe Right Heart Failure Associated With Pulmonary Hypertension　- Protocol for the PHiNO Study.

Phase 2 Study to Evaluate the Efficacy and Safety of Inhaled Nitric Oxide Therapy in Patients With Severe Right Heart Failure Associated With Pulmonary Hypertension　- Protocol for the PHiNO Study.